Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer

SIMPLE SUMMARY: Radioiodine therapy is the main treatment option for metastatic differentiated thyroid cancer (DTC). However, only half of these patients achieve (partial or complete) remission or have stable disease during long-term follow-up. In the remaining ones, disease progresses mainly as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Petranović Ovčariček, Petra, Campenni, Alfredo, de Keizer, Bart, Deandreis, Desiree, Kreissl, Michael C., Vrachimis, Alexis, Tuncel, Murat, Giovanella, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486510/
https://www.ncbi.nlm.nih.gov/pubmed/37686566
http://dx.doi.org/10.3390/cancers15174290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486510/
https://www.ncbi.nlm.nih.gov/pubmed/37686566
http://dx.doi.org/10.3390/cancers15174290

Ejemplares similares